ADLIB - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79169309
Serial Number
79169309
Registration Number
5139363
Word Mark
ADLIB
Status
700 - Registered
Status Date
2017-02-14
Filing Date
2015-04-28
Registration Number
5139363
Registration Date
2017-02-14
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2016-11-29
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
MAHONEY, PAULA M
Statements
Certificate of Correction for Registration
In the statement, "the entire class 042" should be deleted, and Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; design and development of medical technology; research and development in the field of biotechnology; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; clinical trials for others; technical project studies in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical research in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical project planning in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; research and development of new products for others; design and development of computer software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; providing temporary use of non-downloadable business software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; rental of computer software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; cloud computing featuring software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals should be inserted.
Goods and Services
Monoclonal antibodies for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; peptides and proteins for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; biological and chemical preparations and reagents for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicines for human purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicines for dental purposes, namely, for infectious diseases, neurological diseases or inflammatory diseases; medicines for veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicinal preparations, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; living cells for manufacturing monoclonal antibodies used for medical purposes; cell lines for manufacturing monoclonal antibodies used for medical purposes; living cells for manufacturing monoclonal antibodies used for veterinary purposes; cell lines for manufacturing monoclonal antibodies used for veterinary purposes; biological tissue cultures for medical purposes, namely, for cultivating living cells or cell lines used for manufacturing monoclonal antibodies; surgical implants comprised of living tissues; biological implants, namely, a vital processed human or animal connective tissue; disinfectants for hygiene purposes; sanitary sterilising preparations; biocides; preparations for destroying vermin
Goods and Services
[Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; design and development of medical technology; research and development in the field of biotechnology; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; clinical trials for others; technical project studies in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical research in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical project planning in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; research and development of new products for others; design and development of computer software for use with medical technology; software design and development; providing temporary use of non-downloadable business software; rental of computer software; cloud computing featuring software used for development of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products] * Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; design and development of medical technology; research and development in the field of biotechnology; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; clinical trials for others; technical project studies in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical research in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical project planning in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; research and development of new products for others; design and development of computer software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; providing temporary use of non-downloadable business software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; rental of computer software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; cloud computing featuring software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals *
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-07-25
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2015-07-25
Primary Code
042
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
M. Scott Alprin
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1257063
International Registration Date
2015-04-28
International Publication Date
2015-07-23
International Renewal Date
2025-04-28
Auto Protection Date
2017-01-23
International Status
001 - Request for extension of protection established
International Status Date
2015-07-23
Priority Claimed In
True
Priority Claimed Date
2014-10-30
First Refusal In
True
Trademark Events
Event DateEvent Description
2015-07-23SN ASSIGNED FOR SECT 66A APPL FROM IB
2015-07-25NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2015-07-29APPLICATION FILING RECEIPT MAILED
2015-08-08ASSIGNED TO EXAMINER
2015-08-13NON-FINAL ACTION WRITTEN
2015-08-14NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2015-08-14REFUSAL PROCESSED BY MPU
2015-08-14NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2015-09-04REFUSAL PROCESSED BY IB
2016-02-15TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2016-02-15ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2016-02-15TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-02-15CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-02-16TEAS/EMAIL CORRESPONDENCE ENTERED
2016-03-10SUSPENSION LETTER WRITTEN
2016-03-10LETTER OF SUSPENSION E-MAILED
2016-03-10NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2016-09-15ASSIGNED TO LIE
2016-09-19LIE CHECKED SUSP - TO ATTY FOR ACTION
2016-09-23TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2016-09-23CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-09-24TEAS/EMAIL CORRESPONDENCE ENTERED
2016-10-13APPROVED FOR PUB - PRINCIPAL REGISTER
2016-10-27LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-11-09NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-11-09NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2016-11-09NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2016-11-29PUBLISHED FOR OPPOSITION
2016-11-29OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-12-16TEAS POST PUBLICATION AMENDMENT RECEIVED
2016-12-16NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
2016-12-28NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
2016-12-28NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2017-01-31ASSIGNED TO PETITION STAFF
2017-02-01APPLICANT SUPPLIED CHANGES/CORRECTIONS AFTER PUB APPROVAL NOT ENT
2017-02-14REGISTERED-PRINCIPAL REGISTER
2017-03-09TEAS SECTION 7 REQUEST RECEIVED
2017-05-14FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2017-06-06ASSIGNED TO PARALEGAL
2017-06-23CERTIFICATE OF CORRECTION ISSUED
2017-08-04NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
2017-09-15FINAL DISPOSITION PROCESSED
2017-09-15FINAL DISPOSITION NOTICE SENT TO IB
2017-10-28FINAL DECISION TRANSACTION PROCESSED BY IB
2018-02-23PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
2018-03-07INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE